Polomar Health Services, Inc.
- Close
- Oct 23, 2026 · +0.00%
- Market cap
- $3.69M
- 28.38M shares
- Filings
- 152
Q3 2026+1,002.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2024derived
—Q3 2026N/M FY25 yoy
Q1 2026+2,034.6% FY25 yoy
- $3.69M
- —
- 0.8×
- —
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 23, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $648,231 | reported | |
| FY 2024 | 2024-12-31 | $58,824 | reported | |
| FY 2023 | 2023-12-31 | $41,844 | reported | |
| FY 2022 | 2022-12-31 | $34,526 | reported |
Pharmaceutical preparations
Polomar Health Services, Inc. is the 222nd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ONCOOnconetix, Inc.$815.4K67.7%1,721.0%$2.5MMCRBSeres Therapeutics, Inc.$789.0K—721.9%$14.4MLEXXLexaria Bioscience Corp.$705.9K52.0%1,686.0%$102.4M
PMHSPolomar Health Services, Inc. (this company)$648.2K1,002.0%1,650.8%$3.7M
BTAIQBioXcel Therapeutics, Inc.$642.0K71.7%10,887.4%$313.1KELABPMGC Holdings Inc.$590.1K—1,313.0%$1.9MYARWYarrow Bioscience, Inc.$570.0K13.8%4,646.1%$296.8MSLNSilence Therapeutics plc$559.0K98.7%15,851.9%$3.7BQUCYQuantum Cyber N.V.$537.1K39.9%3,018.3%$49.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Polomar Health Services, Inc. · CIK 1265521 · Engraved from SEC EDGAR